China NMPA Drug Inspection - Guangxi Zhongsen Traditional Chinese Medicine Pharmaceutical Co., Ltd. - Bletilla striata
China NMPA drug inspection for Guangxi Zhongsen Traditional Chinese Medicine Pharmaceutical Co., Ltd. published December 29, 2017. Drug: Bletilla striata. The State Administration for Market Regulation (now NMPA) issued an announcement on December 29, 2017, detailing finding
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Guangxi Zhongsen Traditional Chinese Medicine Pharmaceutical Co., Ltd. published December 29, 2017. Drug: Bletilla striata. The State Administration for Market Regulation (now NMPA) issued an announcement on December 29, 2017, detailing finding
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox